Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders

The purpose of this notice is to advise stakeholders that Health Canada is proposing to: maintain the flexibilities and regulatory oversight provided by the Interim order respecting clinical trials for medical devices and drugs relating to COVID-19 until at least the fall of 2021, and bring forward regulatory amendments that would allow the flexibilities under the Interim Order to continue after the fall of 2021.

Data and Resources

Additional Info

Field	Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French)	Garantir la prévisibilité des essais cliniques relatifs à la COVID-19 et proposition concernant la conservation des registres d’essais cliniques : Avis aux intervenants
Update Frequency	as_needed
Geographic Scope	[]
Criticality Level	[]
Sensitivity Level	unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published	2020-12-10 00:00:00
Open Canada Date Modified
Open Canada Subject	["health_and_safety"]
Open Canada Keywords	{"fr": ["COVID-19", "pandémie", "prévisibilité", "surveillance réglementaire", "essais cliniques COVID-19", "essais cliniques", "dispositifs médicaux et médicaments", "avis aux parties prenantes", "arrêté d'urgence", "modifications réglementaires"], "en": ["COVID-19", "pandemic", "predictability", "regulatory oversight", "COVID-19 clinical trials", "clinical trials", "medical devices and drugs", "notice to stakeholders", "Interim Order", "regulatory amendments"]}
Open Canada Collection	publication
Principal Organization
Reference Data
Official Source